Stay updated on Eteplirsen in DMD Patients Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen in DMD Patients Clinical Trial page.

Latest updates to the Eteplirsen in DMD Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and methodologies related to the efficacy and safety of eteplirsen in Duchenne Muscular Dystrophy (DMD) patients, while also updating the version number from v2.14.4 to v2.15.0.SummaryDifference14%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check67 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Eteplirsen in DMD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen in DMD Patients Clinical Trial page.